Coronavirus vaccine

Covishield and Covaxin What do we know about Indian vaccines?

Preliminary data from its 3rd phase of clinical trials indicate that the domestically produced and government-backed Covaxin in India has an efficacy rate of 81%. The use of the Oxford-AstraZeneca vaccine, also known as Covishield, has also been approved in India.

Pfizer vaccine effectiveness and its side effects

During its clinical trial the vaccine has been injected to approximately 43,538 volunteers of different race, origin & Country., Among this only 10% of then acquired the disease, this becomes the great breakthrough news in this pandemic.